Nine Labs Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24232TG2008PTC057818 Incorporated 26 February 2008 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma MSME · Small
Data last updated
Revenue · FY 2025
₹2.08 Cr
▼ 34% YoY
Net profit · FY 2025
₹7.25 Lakh
Net margin 3.5%
EBITDA · FY 2025
₹1.05 Cr
EBITDA margin 50.8%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
18 yrs
Est. 2008
Directors on board
2
As per MCA filings
Active GSTINs
1
of 2 registered

About Nine Labs Private Limited

Data last updated:

Nine Labs Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 February 2008 and has been in existence for over 18 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2008PTC057818. Its GSTIN is 36AADCN7670B1ZJ (Telangana). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Munnamgi Radhika Reddy and Munnamgi Anoushka Reddy.

Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sy No 71 & 72 H No 2 – 159/15 Prapurna Enclave Suchitra Circle Jeedimetla, Hyderabad, Telangana, India – 500067.

As per the financials filed for FY 2025, the company reported a revenue of ₹2.08 Cr, a decline of 34% compared to the previous year. For the same year it recorded a net profit of ₹7.25 Lakh (net margin 3.5%) and EBITDA of ₹1.05 Cr (EBITDA margin 50.8%). Revenue has declined at a compounded annual rate (CAGR) of 33% over three years and 30% over five years.

Court records list 3 cases involving the company, including 3 filed by the company; 2 cases are pending.

Nine Labs Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0020264). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ninelabs.co.in.

Company Details of Nine Labs Private Limited
CIN U24232TG2008PTC057818
Registration Number 057818
Incorporation Date 26 February 2008
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-20-0020264

CIN History

Nine Labs has one previous CIN (Corporate Identification Number): U24232AP2008PTC057818. The current CIN is U24232TG2008PTC057818, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24232TG2008PTC057818Current
U24232AP2008PTC057818Previous

Recognitions & Rankings of Nine Labs

MSME (Udyam registered) Ministry of MSME
Category
Small (2023-24)
Udyam number
UDYAM-TS-20-0020264
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
  • Registered Address
    Sy No 71 & 72 H No 2 – 159/15 Prapurna Enclave Suchitra Circle Jeedimetla, Hyderabad, Telangana, India – 500067
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Nine Labs Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full report on Nine Labs

Financials, compliance, directors, charges, ownership and filings for Nine Labs Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity

The main business activity of Nine Labs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical productsLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Financials of Nine Labs Private Limited

FY 2025 filings available

Nine Labs Private Limited reported revenue of ₹2.08 Cr (down 34% YoY) for FY 2025.

Revenue · FY 2025
₹2.08 Cr ▼ 34%
Net profit · FY 2025
₹7.25 Lakh margin 3.5%
EBITDA · FY 2025
₹1.05 Cr margin 50.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 34%
3 years · compounded
▼ 33%
5 years · compounded
▼ 30%
EBITDA CAGR growth
1 year
▲ 293%
3 years · compounded
▲ 16%
5 years · compounded
▲ 7%

Revenue has declined at a compounded annual rate (CAGR) of 30% over five years, including a 34% fall in the latest year. EBITDA rose 293% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2020-21 to FY 2023-24in the company report
Profit and Loss Statement
Revenue from Operations••••
Other Income••••
Total Revenue••••
Cost of Materials Consumed••••
Employee Benefit Expense••••
Finance Costs••••
Depreciation and Amortisation••••
Other Expenses••••
Total Expenses••••
EBITDA₹1.05 Cr
Profit Before Tax••••
Tax Expense••••
Net Profit (PAT)₹7.25 Lakh
Balance Sheet
Share Capital••••
Reserves and Surplus••••
Net Worth (Total Equity)••••
Long-term Borrowings••••
Short-term Borrowings••••
Trade Payables••••
Total Liabilities••••
Fixed Assets••••
Investments••••
Inventories••••
Trade Receivables••••
Cash and Bank Balance••••
Total Assets••••

Financial Ratios

MetricsFY 2024-25FY 2020-21 to FY 2023-24in the company report
Profitability
EBITDA Margin50.8%
Net Profit Margin3.5%
Return on Equity (ROE)••••
Return on Capital Employed (ROCE)••••
Return on Assets (ROA)••••
Liquidity and Debt
Current Ratio••••
Quick Ratio••••
Debt-to-Equity Ratio••••
Interest Coverage Ratio••••
Efficiency and Growth
Asset Turnover••••
Receivable Days••••
Payable Days••••
Inventory Days••••
Revenue Growth••••
Net Profit Growth••••

Paid data: the figures shown as dots, and every line for FY 2020-21 to FY 2023-24, are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Nine Labs are in the company report.

Financial statements from 2015: available in the company report

Board of Directors of Nine Labs Private Limited

Nine Labs has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Munnamgi Radhika ReddyDirector26 Feb 200818 Years 7 MonthsCurrent
Munnamgi Anoushka ReddyDirector05 Jul 20197 Years 3 MonthsCurrent

Peer Comparison

Nine Labs Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Relic Biotechnology Private Limited₹2.09 Cr (FY 2025)••••••••-8.0%••••Pune, Maharashtra, India
Phenix Pharma Private Limited₹2.09 Cr (FY 2022)••••••••-31.0%••••Vadodara, Gujarat, India
Seven Hiills Softgel Private Limited₹2.08 Cr (FY 2021)••••••••20.0%••••Hyderabad, Telangana, India
Zebx Pharmaceuticals Private Limited₹2.08 Cr (FY 2025)••••••••492.0%••••Aramane Nagar, Karnataka, India
Nine Labs Private Limited this company₹2.08 Cr (FY 2025)••••••••-34.0%••••Hyderabad, Telangana, India
Macromed Pharmaceuticals Private Limited₹2.07 Cr (FY 2020)••••••••-1.0%••••Puducherry, India
Forel Labs Private Limited₹2.05 Cr (FY 2024)••••••••-87.0%••••Hyderabad, Telangana, India

Peers are the companies nearest to Nine Labs by revenue, above and below it, in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details

Nine Labs Private Limited is audited by M V NARAYANA REDDY AND CO for the financial year 2024.

NameStatusAppointment DateCessation Date
M V NARAYANA REDDY AND COLockedLockedLocked

Complete auditor history: available in the company report

Ownership and Shareholding

Shareholding and ownership data: available in the company report

Charges & Borrowings

Nine Labs Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance

Employment history and EPFO contributions of people linked to Nine Labs.

Employee and EPFO history: available in the company report

Recent Activity

Nine Labs Private Limited has 6 board changes on record since 2008: 2 appointments and 4 cessations. The latest: Narender Reddy Nalla ceased to be Director on 19 Dec 2019.

AGM
Nine Labs Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Filing
Nine Labs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Narender Reddy Nalla ceased to be Director.
Ceased
Munnamgi Anoushka Reddy ceased to be Additional Director.
Appointed
Munnamgi Anoushka Reddy was appointed as Director.
Ceased
Narasimha Reddy Enukonda ceased to be Director.
Ceased
Kiran Kumar Nalamothu ceased to be Director.
Appointed
Munnamgi Radhika Reddy was appointed as Director.
Incorporation
26 Feb 2008
Nine Labs Private Limited was registered on 26 Feb 2008 with Roc Hyderabad & aged 18 years 7 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts

Credit ratings, litigation, and regulatory alerts: available in the company report

MSME Payment Delays

MSME payment history: available in the company report

Subsidiaries & Group Companies

Corporate group structure: available in the company report

GST Compliance

Nine Labs has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
36AADCN7670B1ZJTelanganaActive01 Jul 2017

GST registrations and filing compliance: available in the company report

MCA Filings & Documents

MCA filings and documents: available in the company report

Frequently Asked Questions

Nine Labs is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 26 February 2008 (18+ years old) and is registered under CIN U24232TG2008PTC057818.

Nine Labs has 2 current directors:

The latest financial statements of Nine Labs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Nine Labs is 36AADCN7670B1ZJ, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Nine Labs is U24232TG2008PTC057818. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Nine Labs has 3 court cases on record: 3 filed by the company. 2 are pending.

Nine Labs was incorporated on 26 February 2008, making it 18+ years old. It is registered with the Registrar of Companies, Hyderabad.

The peers of Nine Labs by revenue are Relic Biotechnology Private Limited, Phenix Pharma Private Limited, Seven Hiills Softgel Private Limited, Zebx Pharmaceuticals Private Limited, Macromed Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Narender Reddy Nalla ceased to be Director on 19 Dec 2019. Munnamgi Anoushka Reddy ceased to be Additional Director on 29 Jul 2019. Munnamgi Anoushka Reddy was appointed as Director on 05 Jul 2019. Nine Labs has 6 board changes on record in total.

Yes, Nine Labs is registered as a small enterprise under Udyam registration (number: UDYAM-TS-20-0020264).

Nine Labs can be reached through the website ninelabs.co.in. Its registered office is in Hyderabad, Telangana, India.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available